What if one of the ultimate keys to transforming obesity treatment lies not in suppressing appetite, but in fundamentally altering how the body’s cellular infrastructure manages and utilizes energy?
Researchers at the Weizmann Institute of Science have identified a remarkable protein switch that influences whether cells burn fat or store it. Disabling this protein increases fat consumption and interferes with the formation of new fat cells, raising the possibility of a radically different approach to treating obesity. Subsequent research has strengthened the discovery, revealing that the same protein helps regulate how much energy the body burns.
Led by Professor Atan Gross and doctoral student Sabita Chourasia, the research team focused on a protein called MTCH2, affectionately nicknamed "Mitch." This crucial protein plays a foundational role in controlling cellular metabolism. When scientists disabled this protein in laboratory experiments, cells began consuming more fuel, including fats and carbohydrates. They also found that removing Mitch could interfere with the complex biological process through which immature precursor cells develop into mature fat-storing cells.
The discovery builds significantly on earlier experiments conducted in mice, in which switching off Mitch specifically within muscle tissue increased energy expenditure, dramatically improved physical endurance, and protected the animals from diet-induced obesity.
The findings, published in The EMBO Journal in January 2025, suggest that manipulating this protein could eventually offer a reliable way to influence both fat burning and fat accumulation simultaneously. Additional research published later that year provided further concrete evidence of its fundamental importance in regulating overall body fat and systemic metabolism.
Why Scientists Are Searching for Better Obesity Treatments
Over the past decade, medications designed to promote weight loss have fundamentally transformed the landscape of obesity treatment. Breakthrough pharmaceutical interventions such as semaglutide and tirzepatide have helped millions of patients achieve substantial reductions in body weight, largely by influencing appetite signaling and the body’s physiological responses to food.
Yet, losing weight does not necessarily mean losing only fat.
Weight reduction initiatives can also involve a concurrent decline in lean body mass, which critically includes muscle and other vital supportive tissues. Preserving muscle is especially important because it underpins physical strength, overall mobility, and long-term metabolic health.
A comprehensive 2026 analysis of 20 clinical trials involving 15,782 participants found that lean mass accounted for approximately 25% to 39% of the total weight lost with several widely prescribed weight-loss medications. Importantly, the researchers noted that comparable proportional losses also occurred with traditional lifestyle interventions, while adding structured resistance training helped preserve significantly more lean tissue.
These widespread concerns have heavily encouraged scientists to investigate innovative ways to reduce excess body fat while actively protecting the muscles needed for lifelong health and vitality.
Professor Gross and his colleagues at the Weizmann Institute arrived at a promising potential avenue through an unexpected discovery involving the Mitch protein.
Switching Off One Protein Protected Mice From Obesity
In earlier experimental phases, Gross’s team successfully reduced the activity of MTCH2 within the muscle tissues of test mice. The physiological effects were striking.
The genetically modified animals demonstrated markedly increased metabolic activity and proved entirely resistant to obesity caused by high-fat diets. Their muscles also developed a greater density of fibers equipped with a high capacity for utilizing oxygen, which substantially improved their overall physical endurance.
The mice performed visibly better in rigorous exercise and physiological stress tests, alongside notable improvements in cardiovascular and heart function. In addition to resisting excess fat accumulation, they experienced favorable, positive changes in their overall body composition.
The empirical results suggested that Mitch was doing much more than simply controlling a single isolated metabolic reaction. Somehow, this specific protein appeared to orchestrate the body’s fundamental ability to balance energy usage, govern fat storage, and sustain physical activity under metabolic stress.
That outcome raised an intriguing scientific question: How could disabling a single protein produce such widespread, systemic metabolic effects?
To investigate further, the researchers turned their critical focus toward mitochondria, the microscopic cellular structures universally responsible for supplying much of the energy that living cells require to function.
The Mitochondria Connection Behind Fat Burning
Mitochondria are frequently described as the microscopic powerhouses of cells because they convert chemical energy derived from food into a universally usable form of energy known as ATP, or adenosine triphosphate.
ATP acts as the primary cellular energy currency. Muscles require it to contract, living cells need it to grow and repair themselves, and countless complex biological processes depend on an uninterrupted supply.
However, mitochondria are far from static structures. They constantly change shape, dynamically joining together into larger interconnected networks or separating into smaller, isolated units.
When mitochondria undergo fusion, they can form sprawling collaborative systems that help coordinate efficient energy production. When they divide, the resulting structures may operate differently, altering how efficiently cells produce and consume chemical energy.
Gross’s team had previously established that Mitch plays a major regulatory role in mitochondrial fusion, the cellular process that allows separate mitochondria to merge together.
Without this protein, the intricate mitochondrial network becomes heavily fragmented. Although the affected cells can still generate energy, they experience alterations in energy efficiency and demand that can force them to consume substantially more fuel.
This offered a compelling potential explanation for the unusual metabolism observed in the mice. Instead of conserving energy efficiently, their cells appeared to be operating in a heightened, energy-intensive state.
But would disabling Mitch trigger a similar metabolic shift in human cells?
Human Cells Begin Burning More Fat Without Mitch
To answer that critical question, researchers led by doctoral student Sabita Chourasia used advanced genetic engineering techniques to remove MTCH2 from human cells grown in laboratory cultures.
The genetic deletion severely disrupted the normal architecture of their mitochondrial networks. Individual mitochondria became far more separated, and the delicate balance between cellular energy production and energy demand shifted.
The cells developed a persistent shortage of readily available energy relative to their actual metabolic needs, even as their mitochondria increased their oxygen-consuming activity.
To compensate for this internal energy deficit, the cells began consuming significantly more nutrients.
"After deleting Mitch, we examined, every few hours, the effect that had on more than 100 substances taking part in metabolism in human cells," Chourasia explains. "We saw an increase in cellular respiration, the process in which the cell produces energy from nutrients, such as carbohydrates and fats, using oxygen. This explains the increase in muscular endurance in previous experiments using mice."
Cellular respiration represents the vast series of chemical reactions that allow cells to extract usable energy from circulating nutrients. Increasing this metabolic activity generally requires a much greater supply of fuel.
The researchers found that human cells lacking Mitch consumed notably higher amounts of fats, carbohydrates, and amino acids, which serve as the fundamental building blocks of proteins.
The pattern of fat metabolism proved particularly revealing.
Rather than relying on their usual balanced mix of energy sources, the altered cells sharply increased their utilization of fatty acids for fuel. This indicated that MTCH2 influences not only the total volume of energy cells consume, but also dictates precisely which nutrients they utilize to meet that ongoing metabolic demand.
"We discovered that deleting Mitch led to a major drop in fats in membranes," Gross explains. "At the same time, we saw an increase in fatty substances used to produce energy, and we realized that the fat was being broken down from the membrane to be used as fuel. In other words, we showed that Mitch determines the fate of fat in human cells."
Cellular membranes are thin, flexible barriers composed largely of fatty molecules called lipids. They protect cells and organize many of their essential biological functions.
The findings suggested that cells deprived of Mitch were actively reorganizing how they distributed and utilized these structural lipids, drawing down some of their available fatty resources to support heightened energy consumption.
Detailed biochemical analyses also revealed extensive changes in stored lipids, demonstrating that the effect was considerably more complex than simply eliminating cellular fat stores. Overall, the results demonstrated that MTCH2 acts as a powerful gatekeeper of how cells allocate raw nutrients between energy production and other vital biological needs.
Blocking the Formation of New Fat Cells
The research team then investigated whether Mitch similarly influences how fat cells develop from their earliest stages.
This question was particularly compelling because previous scientific studies had identified elevated MTCH2 levels within fat tissue obtained from women diagnosed with obesity.
Fat cells, scientifically known as adipocytes, do not appear fully formed within tissues. They develop from immature precursor cells through a specialized biological process called adipogenesis, or fat cell differentiation.
As these precursor cells mature, they must build new cellular structures, synthesize complex fats, and activate specific genes that allow them to specialize in efficient energy storage.
All of these developmental steps require considerable energy and abundant raw materials.
Gross’s team suspected that removing Mitch might disrupt the process by creating an internal cellular environment in which cells were too busy rapidly consuming fuel to build the structural components required for long-term fat storage.
Experiments utilizing mouse precursor fat cells strongly supported this hypothesis. When the researchers deleted MTCH2, far fewer cells successfully developed into mature adipocytes.
In the published experiments, approximately 80% to 90% of normal precursor cells naturally differentiated within a six-day window, compared with a mere 5% to 10% of cells lacking MTCH2. The genetically altered cells also accumulated substantially fewer lipid droplets, which are the specialized cellular structures dedicated to storing fat.
"When we deleted Mitch from the progenitor cells, we discovered that the environment created in these cells was not conducive to the synthesis of new fats," Gross explains. "Reducing the ability to synthesize membranes prevents the cells from growing, developing and reaching the point where differentiation is possible. The process of fat accumulation requires a large amount of available energy, but in cells without Mitch, there is a shortage of energy. In addition, the expression of genes necessary for differentiation is suppressed, and there is a shortage of the substances vital for this process to occur. As a result, differentiation of new fat cells is reduced, along with fat accumulation."
In essence, disabling Mitch appeared to influence fat metabolism through two distinct pathways. It increased the cellular consumption of energy-rich nutrients while simultaneously interfering with the internal cellular machinery required to develop new fat-storing cells.
Crucially, the fat cell differentiation experiments relied on a mouse-derived cell line, whereas the detailed analysis of nutrient consumption was conducted directly in human cells. The combined results point toward a broad biological role for the protein, though they do not definitively establish that blocking MTCH2 would prevent new fat cells from forming in living human beings.
Follow-Up Research Reveals Another Fat-Burning Mechanism
The profound importance of MTCH2 became even clearer in subsequent research published on October 3, 2025, in the journal Nature Communications.
An international research collaboration, which included both Gross and Chourasia, investigated how MTCH2 specifically influences metabolism within fat tissue. By analyzing human and mouse fat samples, studying cultured fat cells, and conducting complex experiments in genetically modified mice, the scientists successfully identified another molecular mechanism linking the protein directly to whole-body energy expenditure.
They discovered that MTCH2 helps regulate the precise movement of fatty acids into mitochondria, where these molecules can be broken down to produce chemical energy.
This vital process involves an enzyme known as carnitine palmitoyltransferase 1, or CPT1. This specific enzyme functions as an essential biochemical checkpoint, helping determine how much circulating fat is allowed to enter mitochondria to be burned as fuel.
Normally, CPT1 activity is strictly regulated by a cellular molecule called malonyl-CoA, which signals when cells should limit their fatty acid consumption.
The researchers discovered that MTCH2 physically interacts with CPT1 and influences how strongly this regulatory signal affects the enzyme’s function.
Removing MTCH2 fundamentally altered that control system, permitting mitochondria to increase both fatty acid utilization and overall energy expenditure.
This provided a much more detailed molecular explanation for why disabling the protein could reliably encourage cells to burn additional fat.
Mice Burned More Energy Without Eating Less
The comprehensive follow-up study also yielded an especially promising physiological result.
When researchers removed MTCH2 specifically from the fat cells of living mice, the animals burned more overall energy without increasing their spontaneous physical activity or changing the volume of food they consumed.
Under a regular, standard diet, the genetically modified mice gained weight at a rate very similar to that of normal, control mice.
However, when the animals were subjected to a high-fat diet, a distinct difference emerged.
Mice lacking MTCH2 specifically within their fat tissue gained noticeably less weight and accumulated less body fat than untreated mice, despite consuming equivalent amounts of food.
Their lean body mass remained entirely comparable to that of the control animals, indicating targeted fat loss rather than general tissue degradation.
The genetically modified mice also demonstrated improved glucose tolerance, indicating that their bodies were significantly better equipped to manage blood sugar levels after receiving a glucose load. Additionally, their circulating cholesterol levels were lower.
These findings substantially strengthened the scientific evidence that MTCH2 influences whole-body systemic metabolism, rather than simply altering the behavior of isolated cells in a culture dish.
The scientists further observed that these metabolic effects could occur independently of UCP1, a protein traditionally associated with heat production in brown fat. Brown fat is a specialized form of body fat that helps generate heat by burning energy, whereas white fat primarily functions to store excess dietary energy.
Discovering an additional biochemical pathway for increasing energy expenditure could prove vital because it offers researchers another potential therapeutic target for addressing obesity and its related metabolic disorders.
Could This Protein Lead to Better Weight-Loss Treatments?
Taken together, the collective findings suggest that MTCH2 acts as a critical molecular switch linking fat storage, energy consumption, and the developmental programming of fat cells.
The initial experiments demonstrated that removing the protein could increase nutrient consumption in human cells and interfere with fat cell formation in mouse models. The subsequent research further demonstrated that selectively removing MTCH2 from fat tissue could increase overall energy expenditure and protect test mice against excessive weight gain when faced with a high-fat diet.
That unique combination raises the tantalizing possibility of developing novel treatments that change how the human body handles and allocates energy, potentially complementing existing pharmacological medications that primarily work by suppressing appetite.
Nevertheless, several major scientific questions remain unanswered.
Researchers have not yet demonstrated that inhibiting MTCH2 produces safe, sustained weight loss in humans. Furthermore, the protein participates in a wide array of other important biological activities, including vital mitochondrial regulation and pathways essential for general cell survival. Blocking it systemically throughout the entire body could therefore produce unintended, unwanted consequences.
Preventing fat cells from forming is also not necessarily beneficial in every physiological context. Healthy fat tissue plays an essential role in storing excess dietary energy, maintaining systemic blood sugar balance, and producing vital hormones. Disrupting its normal function could potentially redirect circulating fats into internal organs where they might cause severe metabolic harm.
Future researchers will need to carefully determine whether MTCH2 can be targeted safely, which specific tissues would benefit most from intervention, and whether reducing its activity would successfully preserve muscle health while promoting targeted fat loss.
For the time being, established clinical strategies such as resistance exercise and adequate dietary protein intake remain crucial for protecting muscle mass during weight reduction. A 2026 review of clinical trials confirmed that combining lifestyle modifications with targeted resistance training produced a more favorable pattern of lean mass preservation than weight-loss interventions conducted without such exercise.
The ongoing research nevertheless points toward a compelling possibility: Rather than focusing exclusively on how much food the human body takes in, future obesity treatments might also effectively influence how individual cells decide whether to burn energy or store it.
And one unassuming protein, Mitch, appears to be deeply and permanently involved in that critical decision.
Research Team and Publication Details
The original study, titled "MTCH2 controls energy demand and expenditure to fuel anabolism during adipogenesis," was published in The EMBO Journal on January 3, 2025.
The research was led by Sabita Chourasia and Professor Atan Gross at the Weizmann Institute of Science.
Additional key contributors included Dr. Christopher Petucci, Clarissa Shoffler, and Dina Abbasian from the University of Pennsylvania in Philadelphia; Hu Wang and Professor Xianlin Han from the University of Texas at San Antonio; Dr. Ehud Sivan, Dr. Alexander Brandis, Tevie Mehlman, Dr. Sergey Malitsky, Dr. Maxim Itkin, Dr. Ayala Sharp, Dr. Ron Rotkopf, and Dr. Bareket Dassa from Weizmann’s Life Sciences Core Facilities Department; and Dr. Limor Regev and Dr. Yehudit Zaltsman from Weizmann’s Immunology and Regenerative Biology Department.
The follow-up study, titled "MTCH2 modulates CPT1 activity to regulate lipid metabolism of adipocytes," was published in Nature Communications on October 3, 2025, involving a broad international collaboration of researchers affiliated with ETH Zurich, the Weizmann Institute of Science, and other participating academic institutions.
